Quigley Pharma, Inc. Report issue

For profit Phase 2
Founded: Doylestown PA United States (2001)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2006
NCT00568035
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

quercetin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1